Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Chemokines, our body's chemical messengers, play a crucial role in regulating the immune response.  They are secreted by ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

The report forecasts global market growth from $116.1 billion in 2024 to $168 billion by 2029 at a CAGR of 7.7%. Highlighting advances in immunotherapy, CAR-T cell therapy, and biomarker-based ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Cipla has secured USFDA approval to market a generic cancer treatment, specifically paclitaxel protein-bound particles.

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

Researchers explore the role of a high-fat diet in promoting the formation of premetastatic niches and platelet activation.